Alliancebernstein L.P. Fortress Biotech, Inc. Transaction History

Alliancebernstein L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.8 - $1.5 $24,160 - $45,300	-30,200 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.24 - $2.75 $6,076 - $13,475	-4,900 Reduced 13.96%	30,200 $41,000
Q2 2021 Jul 30, 2021	BUY	$3.5 - $5.48 $30,800 - $48,224	8,800 Added 33.46%	35,100 $125,000
Q2 2020 Aug 13, 2020	BUY	$1.83 - $3.16 $48,129 - $83,108	26,300 New	26,300 $70,000
Q1 2019 May 14, 2019	SELL	$0.94 - $2.47 $10,810 - $28,405	-11,500 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$2.92 - $5.1 $33,580 - $58,649	11,500 New	11,500 $34,000

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $185M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.